Dyne Therapeutics 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$3,788
$0
Gross Profit
-400
-386
3,221
-597
EBITDA
-71,562
-68,771
-67,121
-62,273
EBIT
-71,962
-69,157
-67,688
-62,870
Net Income
-65,102
-65,649
-66,638
-60,210
Net Change In Cash
0
0
3,788
0
Free Cash Flow
-55,725
-78,728
-35,088
-50,769
Cash
608,196
272,035
121,626
130,279
Basic Shares
92,507
81,043
61,393
61,109

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-2,461
-3,345
-1,088
-700
EBITDA
-240,489
-169,279
-148,203
-57,947
EBIT
-242,162
-170,962
-149,291
-58,647
Net Income
-235,937
-165,237
-149,283
-58,737
Net Change In Cash
0
0
0
0
Free Cash Flow
-188,887
-156,712
-123,181
-47,669
Cash
121,626
172,147
200,825
300,852
Basic Shares
59,683
51,976
50,895
14,395

Earnings Calls

Quarter EPS
2024-06-30
-$0.70
2024-03-31
-$0.81
2023-12-31
-$1.09
2023-09-30
-$0.99